Literature DB >> 23648068

Towards standardization of clot waveform analysis and recommendations for its clinical applications.

M Shima1, J Thachil, S C Nair, A Srivastava.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23648068     DOI： 10.1111/jth.12287

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  13 in total

1.  A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity.

Authors:  Tomoko Matsumoto; Keiji Nogami; Midori Shima
Journal:  Int J Hematol       Date:  2016-10-11       Impact factor: 2.490

2.  Differences in the Composition of Activated Partial Thromboplastin Time (APTT) Reagents Affect Clot Waveform Analysis.

Authors:  Konami Kato; Yuki Hatayama; Hisashi Shimohiro; Hitomi Ichikawa; Tetsuya Fukuda
Journal:  Yonago Acta Med       Date:  2022-08-29       Impact factor: 1.371

3.  Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study.

Authors:  Bingwen Eugene Fan; Kollengode Ramanathan; Christina Lai Lin Sum; Dheepa Christopher; Stephrene Seok Wei Chan; Gek Hsiang Lim; Chwee Fang Bok; Shiun Woei Wong; David Chien Lye; Barnaby Edward Young; Jia Yan Lim; Rui Min Lee; Shu Ping Lim; Hwee Tat Tan; Mui Kia Ang; Soon Lee Lau; Ponnudurai Kuperan; Kiat Hoe Ong; Yew Woon Chia
Journal:  J Thromb Thrombolysis       Date:  2021-09-28       Impact factor: 5.221

Review 4.  A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis.

Authors:  Marcus D Lancé
Journal:  Thromb J       Date:  2015-01-12

5.  Diagnostic analysis of lupus anticoagulant using clot waveform analysis in activated partial thromboplastin time prolonged cases: A retrospective analysis.

Authors:  Kazunori Kanouchi; Hiroto Narimatsu; Toru Shirata; Keita Morikane
Journal:  Health Sci Rep       Date:  2021-03-12

6.  Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors.

Authors:  Cho Yeow Koh; Norrapat Shih; Christina Y C Yip; Aaron Wei Liang Li; Weiming Chen; Fathiah S Amran; Esther Jia En Leong; Janaki Krishnamoorthy Iyer; Grace Croft; Muhammad Ibrahim Bin Mazlan; Yen-Lin Chee; Eng-Soo Yap; Dougald M Monroe; Maureane Hoffman; Richard C Becker; Dominique P V de Kleijn; Vaishali Verma; Amita Gupta; Vijay K Chaudhary; A Mark Richards; R Manjunatha Kini; Mark Y Chan
Journal:  Nat Commun       Date:  2021-11-25       Impact factor: 14.919

7.  Usefulness of the second-derivative curve of activated partial thromboplastin time on the ACL-TOP coagulation analyzer for detecting factor deficiencies.

Authors:  Naoki Tokunaga; Chihiro Inoue; Toshiyuki Sakata; Kumiko Kagawa; Masahiro Abe; Norimichi Takamatsu; Takayuki Nakao; Toshio Doi
Journal:  Blood Coagul Fibrinolysis       Date:  2016-06       Impact factor: 1.276

8.  Global coagulation assays in hemophilia A: A comparison to conventional assays.

Authors:  Saman Aghighi; Anne Riddell; Christine A Lee; Simon A Brown; Edward Tuddenham; Pratima Chowdary
Journal:  Res Pract Thromb Haemost       Date:  2019-12-29

9.  COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis.

Authors:  Ponnudurai Kuperan; Yew Woon Chia; Bingwen Eugene Fan; Jensen Ng; Stephrene Seok Wei Chan; Dheepa Christopher; Allison Ching Yee Tso; Li Min Ling; Barnaby Edward Young; Lester Jun Long Wong; Christina Lai Lin Sum; Hwee Tat Tan; Mui Kia Ang; Gek Hsiang Lim; Kiat Hoe Ong
Journal:  J Thromb Thrombolysis       Date:  2020-10-24       Impact factor: 2.300

10.  Development and validation of a novel qualitative test for plasma fibrinogen utilizing clot waveform analysis.

Authors:  Atsuo Suzuki; Nobuaki Suzuki; Takeshi Kanematsu; Sho Shinohara; Hiroshi Kurono; Nobuo Arai; Shuichi Okamoto; Naruko Suzuki; Shogo Tamura; Ryosuke Kikuchi; Akira Katsumi; Tetsuhito Kojima; Tadashi Matsushita
Journal:  Sci Rep       Date:  2022-01-21       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.